3/15/2020: https://www.mtec-sc.org/upcoming-solicitations/ The Medical Technology Enterprise Consortium (MTEC) [of which the University of Iowa is a member] is excited to post this pre-announcement for a potential Request for Project Proposals (RPP) focused on the development of prototypes aimed to combat the coronavirus: MTEC-20-09-COVID19 "Prototype Development to Combat COVID-19"
The upcoming RPP(s) will be posted to the MTEC website (mtec-sc.org) and a notice will be posted on www.beta.SAM.gov to notify interested parties. Contingent upon approval from the Government, the upcoming RPP(s) is expected to be released within the next few weeks and will have an extremely short preparation period (approximately 14 days).
*CAUTION: All information contained in this pre-announcement has not been formally approved by the Government, and represents MTEC’s interpretation of the situation at this time (3/15/2020). All information is subject to change.
PROGRAM BACKGROUND: In light of the magnitude and potential threat that the coronavirus (COVID-19) poses to our military’s health and readiness, the Government seeks to rapidly accelerate the inquiry, testing, and fielding of new 21st century capabilities, employing novel technologies and approaches to the detection of exposure, prevention, containment and treatment of COVID-19 and future emerging threats.
This pre-announcement has been developed by MTEC to provide notice for the possibility of one or more upcoming RPPs focused on combating COVID-19. This notice may also help the membership form appropriate partnerships/teaming relationships so that they are poised to respond to the full requirements described in potential upcoming RPPs. CAUTION: These solution requirements have not been formally established by the Government, and are solely MTEC’s interpretation of the critical needs of the U.S. military.
MTEC believes that an emphasis will be placed on technologies that can be deployed as soon as possible but no later than 31 December 2020. In support of this, MTEC has identified the following potential areas of interest:
- Point-of-care diagnostic that provides rapid and accurate determination on exposure to COVID-19.
- Prophylactic(s)/Therapeutic(s) that can prevent and/or treat in a rapid manner (few hours to 2 days) potentially in a non-hospital environment. Repurposing FDA-approved drugs/biologics for prevention/treatment of COVID-19 or testing of drugs/biologics that have already demonstrated safety in humans for the prevention/treatment of COVID-19 are preferred.
- Disease predictive modeling that provides early warning through data capture from several different streams of data to include social media and artificial intelligence (AI) parameter decision tools that would provide actionable information to medical service providers and command structures.
- Patient monitoring, tracking, and management system for in-home or non-hospital environment patient tele-health services to include interface into the Cerner electronic health record.